Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics
GET POWR RATINGS... FREE!
CRON POWR Grades
- CRON scores best on the Sentiment dimension, with a Sentiment rank ahead of 13.5% of US stocks.
- CRON's strongest trending metric is Quality; it's been moving down over the last 157 days.
- CRON ranks lowest in Quality; there it ranks in the 0th percentile.
CRON Stock Summary
- For CRON, its debt to operating expenses ratio is greater than that reported by merely 9.49% of US equities we're observing.
- With a price/sales ratio of 25.8, Cronos Group Inc has a higher such ratio than 93.17% of stocks in our set.
- Revenue growth over the past 12 months for Cronos Group Inc comes in at 81.99%, a number that bests 91.84% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cronos Group Inc are AXGN, REKR, ISR, VCYT, and SNES.
- Visit CRON's SEC page to see the company's official filings. To visit the company's web site, go to www.thecronosgroup.com.
CRON Valuation Summary
- CRON's EV/EBIT ratio is -10; this is 134.13% lower than that of the median Healthcare stock.
- Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
- Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
Below are key valuation metrics over time for CRON.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CRON | 2021-08-31 | 43.4 | 1.5 | -16.8 | -10.0 |
| CRON | 2021-08-30 | 42.1 | 1.5 | -16.3 | -9.5 |
| CRON | 2021-08-27 | 42.5 | 1.5 | -16.5 | -9.7 |
| CRON | 2021-08-26 | 42.1 | 1.5 | -16.3 | -9.5 |
| CRON | 2021-08-25 | 42.7 | 1.5 | -16.5 | -9.8 |
| CRON | 2021-08-24 | 43.3 | 1.5 | -16.7 | -10.0 |
CRON's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
- CRON's asset turnover comes in at 0.03 -- ranking 353rd of 682 Pharmaceutical Products stocks.
- 500 - Internal server error
The table below shows CRON's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.030 | -0.621 | -0.378 |
| 2021-03-31 | 0.027 | -0.439 | -0.870 |
| 2020-12-31 | 0.024 | -0.553 | -0.242 |
| 2020-09-30 | 0.019 | -0.749 | 0.191 |
| 2020-06-30 | 0.015 | -1.350 | 2.033 |
| 2020-03-31 | 0.014 | -1.185 | 6.271 |
CRON Price Target
For more insight on analysts targets of CRON, see our CRON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $6.63 | Average Broker Recommendation | 2.42 (Moderate Sell) |
CRON Stock Price Chart Interactive Chart >
CRON Price/Volume Stats
| Current price | $3.93 | 52-week high | $15.83 |
| Prev. close | $3.90 | 52-week low | $3.74 |
| Day low | $3.79 | Volume | 1,915,200 |
| Day high | $3.94 | Avg. volume | 2,353,320 |
| 50-day MA | $4.55 | Dividend yield | N/A |
| 200-day MA | $6.53 | Market Cap | 1.47B |
Cronos Group Inc. - Common Share (CRON) Company Bio
Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.
Latest CRON News From Around the Web
Below are the latest news stories about Cronos Group Inc that investors may wish to consider to help them evaluate CRON as an investment opportunity.
Cronos Group Provides Bi-Weekly MCTO Status UpdateTORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). On November 9, 2021, the Company announced that it applied for a management cease trade order (“MCTO”) with the applicable securities regulatory authorities in Canada on the basis that the Company would |
2 Pot Stocks To Flat Out Avoid in 2022Despite the dip last year, the marijuana industry consists of excellent growth stocks that have the potential to flourish in the coming years. The U.S. cannabis companies, in particular, saw drastic revenue growth amid the ongoing pandemic. The ramp-up of state legalization also gave a boost to marijuana sales. |
Are Any Marijuana Stocks On U.S. Exchanges Buys After Tilray Gives Sector A Break?The descent for Canadian marijuana stocks continued last year, as expectations dimmed for cannabis reform in the U.S. |
7 Penny Stocks to Buy for JanuaryThese penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months. |
Why Cronos Group Stock Slumped 14% in DecemberThe company delayed the release of an SEC filing and got dragged down by the broad downturn in cannabis stocks. |
CRON Price Returns
| 1-mo | -8.82% |
| 3-mo | -32.24% |
| 6-mo | -45.64% |
| 1-year | N/A |
| 3-year | -73.62% |
| 5-year | 183.78% |
| YTD | 0.26% |
| 2021 | -43.52% |
| 2020 | -9.52% |
| 2019 | -26.18% |
| 2018 | 34.43% |
| 2017 | 600.87% |
Continue Researching CRON
Here are a few links from around the web to help you further your research on Cronos Group Inc's stock as an investment opportunity:Cronos Group Inc (CRON) Stock Price | Nasdaq
Cronos Group Inc (CRON) Stock Quote, History and News - Yahoo Finance
Cronos Group Inc (CRON) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...